Companies: 10,795·Total market cap: $144.5T
Medexus Pharmaceuticals Inc.

Medexus Pharmaceuticals Inc.

MEDXFOTCHealthcare● Active
$2.78
+$0.01(+0.36%)
Market Cap$89940464
P/E Ratio
52W High$3.042
52W Low$1.8
Overview

Medexus Pharmaceuticals Inc. (MEDXF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · MEDXF · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.01medxf eps ttm · medxf earnings per shareEarnings history
PE Ratio (TTM)medxf pe ratio ttm · medxf price to earningsPE Ratio deep dive
Revenue (TTM)$99.4Mmedxf revenue ttm · medxf annual revenueFull revenue history
Dividend YieldNo Dividenddoes medxf pay dividends · medxf dividend yieldDividend history
Shares Outstanding25.8Mmedxf shares outstanding · medxf floatShares outstanding history
Next EarningsJun 30, 2026Est.medxf earnings date · medxf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$108.3M▼ 4.18% YoY
202320242025
medexus pharmaceuticals inc. revenue · medxf revenue 2025
FY 2025Net Income$2.2M▲ +1150.00% YoY
202320242025
medexus pharmaceuticals inc. net income · medxf profit 2025
FY 2025EPS$0.08▲ +985.26% YoY
202320242025
medxf eps · medexus pharmaceuticals inc. earnings per share 2025
TTM:Revenue: $99.4MNet Income: -$272000.00EPS: $-0.01View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold1 analystsis medxf a buy · medxf analyst rating
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$2.78Current
$Avg Target
$High
medxf price target · medxf 12 month forecast

Total: 1 · Buy rate: 0.0%

Stock Performance

Full History
1D+0.36%
1W+0.16%
1M-3.65%
3M+24.87%
YTD+31.97%
1Y+30.73%
5Y-55.59%

About Medexus Pharmaceuticals Inc.

CEOKenneth d'Entremont
IPO DateNov 27, 2017
Employees82
CountryCA

Medexus Pharmaceuticals Inc. is a specialized pharmaceutical firm conducting operations across both Canada and the United States. The company's therapeutic focus spans several critical domains, includ…

what is medexus pharmaceuticals inc. · medxf stock overview · medexus pharmaceuticals inc. company profile · who is medexus pharmaceuticals inc. ceo · medxf OTC · medexus pharmaceuticals inc. headquarters · medexus pharmaceuticals inc. business segments

About Stock Overview & Key Data

Medexus Pharmaceuticals Inc. (MEDXF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Nov 27, 2017. As of the latest trading session, MEDXF stock price is $2.78, with a market capitalization of $89.9M. The stock has returned +30.73% over the past 12 months and +31.97% year-to-date.

According to 1 Wall Street analysts, the consensus rating for Medexus Pharmaceuticals Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Medexus Pharmaceuticals Inc. reported revenue of $108.3M and net income of $2.2M. For detailed data — including Medexus Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Medexus Pharmaceuticals Inc. (MEDXF) stock price is $2.78. The stock is traded on OTC under the ticker symbol MEDXF. The 52-week range is $1.80 – $3.04.

MEDXF stock priceMEDXF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice